ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

$1.08
+0.03 (+2.86%)
As of Apr 1, 3:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
34.15M
Net Income
-75,587,845
Gross Margin
43.9%
Profit Margin
-221.3%
Rev Growth
-19.9%
D/E Ratio
1.72
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.9% 43.9% 61.3% 61.3%
Operating Margin -146.3% -131.6% 22.2% 22.8%
Profit Margin -221.3% -210.3% 23.2% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 34.15M 42.63M 7.77M 7.02M
Gross Profit 15.00M 18.73M 4.76M 4.31M
Operating Income -49,951,602 -56,111,385 1.72M 1.61M
Net Income -75,587,845 -84,908,962 1.80M 1.31M
Gross Margin 43.9% 43.9% 61.3% 61.3%
Operating Margin -146.3% -131.6% 22.2% 22.8%
Profit Margin -221.3% -210.3% 23.2% 18.7%
Rev Growth -19.9% -19.9% +3.8% -2.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 13.65M 13.65M 19.50M 20.13M
Total Equity 7.94M 7.94M 23.16M 25.61M
D/E Ratio 1.72 1.72 0.84 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -43,451,403 -51,521,259 2.38M 2.09M
Free Cash Flow 1.78M 1.31M